QIAGEN CLC Genomics

Circulating Tumor Cell Detection and Analysis to Support Malignancy Designation, Tumor-of-Origin Identification, and Treatment Selection

63 views
October 25, 2023
Circulating tumor cells (CTCs) are cells that leave the primary tumor and are intravasated into the blood circulation system. A subset of those make it to other organs and are responsible for metastasis. iCellate’s CellMate platform is a CTC-based liquid biopsy for cancer cell enrichment, detection, and biomarker analysis via a simple blood draw.

In this seminar, you’ll learn:

From Helena Silva Cascales, senior scientist at iCellate Medical AB, how the isolation of whole-tumor cells provides a more comprehensive biomarker analysis, including genomic sequencing and multiplexed protein expression analysis.
From Kashyap Dave, principal scientist at iCellate Medical AB, how DNA from single CTCs can be amplified, sequenced, and analyzed to support malignancy designation and tissue of origin identification using classification analyses under development within Qiagen CLC Genomics Workbench.

Related videos

QIAGEN CLC Genomics

Part I: Single-cell RNA sequencing data analysis using QIAGEN CLC Genomics Workbench

163 views August 21, 2023

This two-part series will walk you through single-cell RNA sequencing...

QIAGEN CLC Genomics

Immune repertoire analysis using QIAGEN CLC Genomics Workbench

89 views August 21, 2023

The composition of the immune repertoire, consisting of the T cell and B...

QIAGEN CLC Genomics

Pathogen detection in wastewater samples using QIAGEN CLC Genomics Workbench

135 views April 24, 2023

In this 90-minute training, you will learn how to easily analyze wastewater...

QIAGEN CLC Genomics

What’s new in QIAGEN CLC Genomics Workbench version 23

388 views February 03, 2023

QIAGEN CLC Genomics Workbench version 23 is here with exciting updates we'd...